1.090USD+5.83%Mkt Cap: 423.55M USDP/E: —Last update: 2026-05-26
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Amer…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap423.55M USD
Enterprise Value-19.70M USD
Revenue (TTM)86.25M USD
Gross Profit42.54M USD
Net Income (TTM)-74.90M USD
Revenue/Share0.2250 USD
Last Price1.090 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees385
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-104.00
PEG—
EV/EBITDA0.29
EV/Revenue-0.23
P/S4.71
P/B0.72
EPS (TTM)-0.13
EPS (Forward)-0.01
52W Range
0.870026% of range1.720
52W High1.720 USD
52W Low0.8700 USD
Profitability
Gross Margin49.86%
Oper. Margin-44.53%
EBITDA Margin-79.08%
Profit Margin-87.77%
ROE-17.65%
ROA-13.19%
Growth
Revenue Growth4.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-74.34M USD
CapEx (TTM)8.30M USD
FCF Margin-15.58%
FCF Yield-3.17%
Net Debt-425.69M USD
Net Debt/EBITDA6.24
Balance Sheet
Debt/Equity0.07
Current Ratio12.36
Quick Ratio11.77
Book Value/Sh1.438 USD
Cash/Share1.166 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)1.550 USD
Target Range1.350 USD – 1.750 USD
# Analysts2
Ownership
Shares Out.390.37M
Float210.57M
Insiders1.50%
Institutions77.01%
Short Interest
Short Ratio3.9d
Short % Float5.01%
Short % Out.3.03%
Shares Short11.82M
Short (prev mo.)10.32M
Technical
SMA 500.9502 (+14.7%)
SMA 2001.223 (-10.9%)
Beta1.31
S&P 52W Chg28.31%
Avg Vol (30d)2.56M
Avg Vol (10d)1.66M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—